Results of a large retrospective analysis of the effect of intended dose intensity of R-CHOP on outcome in a cohort of consecutive, unselected elderly patients with de novo diffuse large B cell lymphoma.

Eyre TA., Salisbury R., Eyre DW., Watson C., Collins GP., Hatton CS.

DOI

10.1111/bjh.13619

Type

Journal article

Publication Date

2016-05-01T00:00:00+00:00

Volume

173

Pages

487 - 491

Total pages

4

Keywords

DLBCL, R-CHOP, dose intensity, elderly, Age Factors, Aged, Aged, 80 and over, Antibodies, Monoclonal, Murine-Derived, Antineoplastic Combined Chemotherapy Protocols, Cohort Studies, Cyclophosphamide, Disease-Free Survival, Doxorubicin, Humans, Infections, Lymphoma, Large B-Cell, Diffuse, Prednisone, Retrospective Studies, Risk Factors, Rituximab, Survival Rate, Treatment Outcome, Vincristine

Permalink More information Close